Monthly M&A Roundup: June 2026 Brand Ownership Changes

June 2026 was the most consequential month for corporate deal-making since February's $250 billion SpaceX/xAI merger — though for a different reason. The deals themselves were measured; the surrounding context was not. SpaceX's June 12 public market debut at $135 per share reshaped how investors think about asset scale entirely. Against that backdrop, six distinct M&A transactions above $3 billion closed or were announced, spanning homebuilding, oncology, semiconductors, defense technology, infrastructure, and financial software. The month closed with deal volume running at its strongest first-half pace since 2021, per PwC's US Deals 2026 midyear outlook.

For May's closings — Shell's C$22B ARC Resources deal, Kone's €34.4B TK Elevator bid, and Mastercard's BVNK stablecoin acquisition advancing through review — see Monthly M&A Roundup: May 2026.

Berkshire Hathaway Acquires Taylor Morrison for $6.8 Billion

Berkshire Hathaway (NYSE: BRK.A, BRK.B) announced on May 31, 2026 a definitive agreement to acquire Taylor Morrison Home Corporation (NYSE: TMHC), one of the ten largest US homebuilders by revenue, in an all-cash transaction at $72.50 per share — a 24% premium to Taylor Morrison's closing price on May 30. The total transaction value is $6.8 billion.

Taylor Morrison builds homes across 11 US states, with primary concentration in Arizona, Texas, Florida, and Georgia. The company had approximately 9,900 home closings in fiscal 2025 and reported $8.1 billion in revenue. Its portfolio spans entry-level, move-up, and active adult communities under the Taylor Morrison and Esplanade brand names.

Why this matters: This is Warren Buffett's largest investment in residential construction since Berkshire acquired Clayton Homes in 2003 for $1.7 billion. US housing supply remains structurally constrained — the National Association of Realtors estimated a shortage of approximately 4.5 million homes as of Q1 2026 — and homebuilders with operational scale and owned land positions are generating strong returns on equity. Taylor Morrison's return on equity was 19.4% in fiscal 2025, above sector peers.

The acquisition folds Taylor Morrison into Berkshire's existing real estate holdings, which include Clayton Homes (manufactured housing), Berkshire Hathaway HomeServices (brokerage), and BNSF Railway's freight network, which moves construction materials. Taylor Morrison's Esplanade active adult communities — marketed directly to buyers aged 55 and older — align with the demographic positioning of Clayton's manufactured housing expansion strategy.

Regulatory review is the primary remaining step. The DOJ review is not expected to be complex given no horizontal overlap with Berkshire's existing businesses. Closing is targeted for Q3 2026. See Berkshire Hathaway's full portfolio.

GSK Acquires Nuvalent for $10.6 Billion: Largest Oncology Deal of the Year

GSK plc (NYSE: GSK; LSE: GSK) entered into a definitive agreement in June 2026 to acquire Nuvalent, Inc. (Nasdaq: NUVL), a Boston-based clinical-stage oncology company, for $124.00 per share in cash — an approximately 73% premium to Nuvalent's 30-day volume-weighted average price before announcement. Total equity value is $10.6 billion.

Nuvalent's lead assets are highly selective ROS1 and ALK inhibitors for non-small cell lung cancer — a tumor type where first- and second-generation inhibitors have significant resistance problems. Its two most advanced programs are zidesamtinib (ROS1) and NVL-655 (ALK), both in Phase II trials with clinical response rates above 80% in heavily pre-treated patient populations. Those numbers are why GSK paid the premium.

Strategic context: GSK has been executing a post-pandemic R&D pivot toward oncology and specialty immunology, exiting consumer health through its Haleon spin-off in 2022. Per GSK's June 2026 announcement, the Nuvalent acquisition "adds three late- and early-stage assets targeting non-small cell lung cancer and other solid tumors, where resistance to current therapies remains the primary unmet need." This is GSK's largest acquisition since its $5.1 billion deal for Sierra Oncology in 2022.

The lung cancer therapeutics market is projected to exceed $35 billion annually by 2030, per EvaluatePharma's 2025 oncology market report. GSK is betting that next-generation selective kinase inhibitors — which target specific mutations with fewer off-target effects — will displace broader-spectrum therapies as genomic profiling becomes standard in oncology practice.

Regulatory review is ongoing across the US, EU, and UK. Closing is targeted for late 2026.

CRH Acquires Arcosa for $8.5 Billion: Infrastructure Materials Consolidation

CRH plc (NYSE: CRH), the Dublin-based building materials group, agreed on June 22, 2026 to acquire Arcosa, Inc. (NYSE: ACA), a Dallas-based producer of construction aggregates, engineered structures, and transportation products, for $150 per share in cash. The offer represents a 25% premium to Arcosa's 60-day volume-weighted average price as of June 18. Total transaction value, including assumed debt, is approximately $8.5 billion.

• Construction Products — aggregates, specialty materials, and recycled aggregates
• Engineered Structures — utility structures, highway products, wind towers
• Transportation Products — hopper barges and marine transportation equipment

Combined with CRH's existing US aggregates operations — CRH is already the largest construction materials supplier in the US by revenue — the acquisition would give CRH dominant scale in Texas, the Southwest, and Mid-Atlantic markets where Arcosa has concentrated operations.

The infrastructure angle: The US Infrastructure Investment and Jobs Act allocated $550 billion for roads, bridges, water systems, and broadband through 2026. Aggregates — crushed stone, sand, gravel — are the foundation of all of that construction. CRH and its peers have been positioning aggressively in aggregates since 2023. CRH acquired Pioneer Natural Resources' sand and gravel operations for $2.1 billion in March 2026. Arcosa adds another 1.5 billion tons of proven mineral reserves.

The transaction is expected to close in Q1 2027, subject to Arcosa shareholder approval and antitrust review. CRH has indicated it is prepared to offer limited asset disposals in markets where combined shares are concentrated.

Qualcomm Acquires Modular for $3.92 Billion: AI Software Push

Qualcomm Incorporated (Nasdaq: QCOM) announced on June 24, 2026 a definitive agreement to acquire Modular, an AI-native development platform company, in an all-stock deal valued at approximately $3.92 billion based on Qualcomm's closing price of $204.13 on June 23.

Modular's core product is MAX, an AI inference engine and developer platform that allows models to run across different hardware — Nvidia GPUs, AMD chips, Qualcomm's own Snapdragon processors, and edge devices — from a single codebase. Its compiler technology, called Mojo, is designed specifically for AI workloads and has gained adoption among AI infrastructure teams at major technology companies.

Per Qualcomm's June 24 press release: "Modular's AI-native platform will advance Qualcomm's evolution as a developer-first, AI solutions company, enabling developers to build, optimize, and deploy AI applications across Qualcomm's full hardware portfolio."

Why Qualcomm is paying: Qualcomm's long-term competitive challenge is convincing AI developers — who currently default to writing code for Nvidia's CUDA platform — to build for Qualcomm's chips instead. Modular's hardware-agnostic platform is Qualcomm's answer to the CUDA lock-in problem. If Modular's developer tools become standard, Qualcomm's chips become a viable runtime target without requiring developers to rewrite their models. The $3.92 billion price reflects the cost of buying developer mindshare, not just software code.

Closing is expected in second half 2026, subject to regulatory approvals. Reuters reported the deal on June 24.

ON Semiconductor Acquires Synaptics for ~$7 Billion: Physical AI Play

onsemi (Nasdaq: ON) announced a definitive agreement to acquire Synaptics Incorporated (Nasdaq: SYNA) in an all-stock transaction with an enterprise value of approximately $7 billion. The deal advances onsemi's push into what the company calls "physical AI" — AI inference running locally on edge devices rather than in cloud data centers.

Synaptics makes human interface solutions and edge AI processors used in laptops, IoT devices, automotive dashboards, and smart home products. Its AIOT (AI for the Internet of Things) chips allow devices to run AI models without a cloud connection. That capability directly complements onsemi's power semiconductors and image sensors.

Per onsemi's announcement: "The combination enables the next generation of intelligent systems for physical AI, combining power efficiency, sensing, and edge inference in a single platform." Synaptics' touchpad controllers appear in roughly 40% of global PC shipments — a distribution advantage onsemi gains with the acquisition.

Consumer impact: Synaptics' technology is embedded in products from Apple, Dell, HP, and major Android device manufacturers. Consumers don't buy Synaptics directly, but the chips processing touch inputs and running on-device AI features in tens of millions of devices globally come from this company. Post-acquisition, that product pipeline moves under onsemi's control.

June 2026 by the Numbers

Source: Company press releases, Reuters, Bloomberg, Kirkland & Ellis deal advisories. Status as of June 30, 2026.

Ongoing Deals from Prior Months

McCormick / Unilever Food Business ($42–45B): The combination of McCormick's spice portfolio with Unilever's food unit — Hellmann's, Knorr, Marmite, Bovril — remained in pre-regulatory review through June. McCormick shareholder vote is expected Q4 2026. Close targeted mid-2027.

Kone / TK Elevator (€34.4B): EU competition authority review is the primary regulatory variable. No close date confirmed. EU competition authority review is expected to require asset disposals in markets where Kone and TK Elevator both have significant operations.

Shell / ARC Resources (C$22B): ARC shareholder vote expected Q3 2026. Canadian Competition Bureau review ongoing. Close targeted late 2026.

Henkel / Olaplex ($1.4B): Regulatory clearances confirmed. Close on track for H2 2026. See Olaplex brand profile.

Warner Bros. Discovery / Paramount Skydance ($110B): DOJ and FTC review ongoing. CNN divestiture widely expected as a regulatory condition.

FAQ

What is the biggest M&A deal announced in June 2026?

By total equity value, GSK's $10.6 billion acquisition of Nuvalent is the largest deal announced in June 2026. CRH's $8.5 billion acquisition of Arcosa is the second largest. Berkshire Hathaway's $6.8 billion purchase of Taylor Morrison and onsemi's ~$7 billion Synaptics deal round out the top four.

What does Berkshire Hathaway get from buying Taylor Morrison?

Taylor Morrison gives Berkshire exposure to the US single-family and active adult homebuilding market — a segment benefiting from structural housing undersupply. The acquisition adds Taylor Morrison's Esplanade brand, approximately 9,900 annual home closings, and land positions across Arizona, Texas, Florida, and Georgia. Berkshire already owns Clayton Homes (manufactured housing) and BNSF Railway (transports construction materials), so Taylor Morrison fits an existing infrastructure ownership pattern.

Why did GSK pay a 73% premium for Nuvalent?

Nuvalent's ROS1 and ALK inhibitors for non-small cell lung cancer showed clinical response rates above 80% in Phase II trials. No approved therapy in the market comes close to those response rates in the same patient populations. GSK paid for the clinical data, not the company's current revenue. Lung cancer drugs with that efficacy profile typically generate $2 to $5 billion in annual peak revenue per approved indication. At $10.6 billion, GSK is pricing in one to two approved indications.

What brands does Qualcomm get from acquiring Modular?

Modular is not a consumer brand. Qualcomm acquires Modular's MAX inference engine, Mojo compiler language, and developer platform relationships with AI teams at major technology companies. The strategic value is in Qualcomm's chip ecosystem — Modular's tools could make Qualcomm's Snapdragon processors a mainstream target for AI model deployment alongside Nvidia's CUDA-based hardware.

How does the CRH Arcosa deal affect consumers?

The Arcosa acquisition does not directly affect consumer brands. CRH and Arcosa produce aggregates, engineered structures, and infrastructure materials sold to contractors and government agencies. The deal's consumer relevance is indirect: consolidated aggregates supply can influence construction costs, which affect residential real estate pricing. In the US markets where Arcosa operates — Texas, Southwest, Mid-Atlantic — CRH's combined market share will be significant.

Related Reading

• Monthly M&A Roundup: May 2026
• Monthly M&A Roundup: April 2026
• Biggest Brand Deals of Q1 2026
• How Berkshire Hathaway Became a Brand Empire
• Brands That Changed Owners in the Last 90 Days
• Browse all News & Updates

Sources

1. Berkshire Hathaway / Taylor Morrison announcement — Bloomberg: https://www.bloomberg.com/news/articles/2026-05-31/berkshire-hathaway-to-buy-taylor-morrison-for-6-8-billion (May 31, 2026) 2. GSK: Agreement to acquire Nuvalent — https://www.gsk.com/en-gb/media/press-releases/gsk-enters-agreement-to-acquire-nuvalent-inc/ (June 2026) 3. CRH: Agreement to acquire Arcosa — https://www.crh.com/media/press-releases/2026/crh-to-acquire-arcosa-leading-u-s-provider-of-aggregates-and-critical-infrastructure-products-for-8-5b/ (June 22, 2026) 4. Qualcomm: Agreement to acquire Modular — Reuters: https://www.reuters.com/business/qualcomm-buy-ai-startup-modular-2026-06-24/ (June 24, 2026) 5. onsemi: Agreement to acquire Synaptics — WSJ: https://www.wsj.com/business/deals/on-semiconductor-to-buy-synaptics-in-all-stock-deal-with-7-billion-enterprise-value-4b5000fc (June 2026) 6. Intellizence: Largest M&A Deals 2026 — https://intellizence.com/insights/merger-and-acquisition/largest-merger-acquisition-deals/ 7. PwC: US Deals 2026 midyear outlook — https://www.pwc.com/us/en/services/consulting/deals/outlook.html 8. StockAnalysis: List of 2026 Mergers & Acquisitions — https://stockanalysis.com/actions/acquisitions/2026/

All brand ownership data verified through WhoBrands.com research methodology. Last updated: July 1, 2026.